Overview
Herceptin is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat metastatic breast cancer in cases where tumors overexpress the HER2 protein and one or more chemotherapy… read more
Overview
Aromasin is a prescription drug approved by the U.S. Food and Drug Administration (FDA) in 2005 to treat estrogen receptor-positive breast cancer after menopause. Aromasin is used as an adjuvant, or… read more
Overview
Perjeta is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat metastatic breast cancer in cases where tumors overexpress the HER2 protein and chemotherapy or anti-HER2 therapy… read more
Overview
Faslodex is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat estrogen receptor-positive breast cancer in postmenopausal women whose cancer progressed after treatment with… read more
Overview
Depending on several factors, you may be eligible to participate in clinical trials studying new treatments for breast cancer. Clinical trials are the only way that new treatments for breast cancer can be… read more
Overview
Chemotherapy is the treatment of cancer with drugs. Chemotherapy drugs may be taken intravenously or orally. Chemotherapy may be given after surgery (referred to as adjuvant chemotherapy), before surgery… read more
Overview
Fareston is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to delay the progression of metastatic, estrogen receptor-positive breast cancer in postmenopausal women. Fareston was… read more
Overview
Tykerb is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat metastatic breast cancer in combination with capecitabine in cases where tumors overexpress the HER2 protein. The… read more
Overview
Tamoxifen is a prescription drug first approved by the U.S. Food and Drug Administration (FDA) in 1977 to treat breast cancer. Tamoxifen was later also approved to prevent breast cancer. Tamoxifen is commonly… read more
Overview
Kadcyla is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat some cases of HER2-positive, metastatic breast cancer. Kadcyla may be prescribed in cases where trastuzumab and a… read more